Alixia

About:

Alixia is a medical research company that engages in developing new modalities to treat cancer, aging, and inflammation.

Website: https://www.alixia.com/

Top Investors: Y Combinator, Eight Capital

Description:

In its quest to develop new ways to fight cancer, aging, and inflammation, Alixia is engaged in medical research. The company utilizes integrate biology, biophysics, computational chemistry, and clinical inputs to drive new therapeutic innovations. The company's lead compounds focus on lead compounds that disrupt the metabolic and inflammatory triggers in both cancer and quasi-cancerous cells in the microenvironment.

Total Funding Amount:

$2.33M

Headquarters Location:

San Francisco, California, United States

Founded Date:

2018-01-01

Contact Email:

info(AT)alixia.com

Founders:

Helen Chen, Olof Mollstedt

Number of Employees:

1-10

Last Funding Date:

2024-07-23

IPO Status:

Private

Industries:

© 2025 bioDAO.ai